GLTO
GLTO
NASDAQ · Biotechnology

Galecto Inc

$25.26
+2.63 (+11.62%)
As of Feb 8, 2:20 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 7.65M 7.80M 6.88M
Net Income -2,097,514 -1,645,262 -1,540,052
EPS
Profit Margin -27.4% -21.1% -22.4%
Rev Growth +8.4% +22.8% +24.7%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 12.99M 11.77M 13.15M
Total Equity 15.26M 17.60M 16.68M
D/E Ratio 0.85 0.67 0.79
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -2,154,773 -2,236,853 -1,912,817
Free Cash Flow -1,120,093 -988,846 -1,121,747